{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:42:04Z","timestamp":1788424924425,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX002490"],"award-info":[{"award-number":["I01BX002490"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR065407"],"award-info":[{"award-number":["AR065407"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ymgme.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T20:25:29Z","timestamp":1535401529000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A bone mineralization defect in the Pahenu2 model of classical phenylketonuria involves compromised mesenchymal stem cell differentiation"],"prefix":"10.1016","volume":"125","author":[{"given":"Steven F.","family":"Dobrowolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina L.","family":"Tourkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Secunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Spridik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.08.010_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2018.08.010_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/bchm2.1934.227.1-4.169","article-title":"Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitat","volume":"277","author":"F\u00f8lling","year":"1934","journal-title":"Hoppe-Seylers Z Physiol Chem"},{"key":"10.1016\/j.ymgme.2018.08.010_bb0015","first-page":"514","article-title":"Phenylpyruvic oligophrenia: Deficiency of phenylalanine oxidizing system","volume":"82","author":"Jervis","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ymgme.2018.08.010_bb0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ymgme.2018.08.010_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgmr.2017.04.006","article-title":"Treatment adherence during childhood in individuals with phenylketonuria: early signs of treatment discontinuation","volume":"28","author":"Garc\u00eda","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2018.08.010_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-015-0378-7","article-title":"Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile","volume":"22","author":"Pena","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.010_bb0035","first-page":"304","article-title":"Phenylketonuria: a review of current and future treatments","volume":"4","author":"Al Hafid","year":"2015","journal-title":"Transl Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.010_bb0040","first-page":"304","article-title":"Phenylketonuria: a review of current and future treatments","volume":"4","author":"Al Hafid","year":"2015","journal-title":"Transl Pediatr."},{"issue":"12(3)","key":"10.1016\/j.ymgme.2018.08.010_bb0045","article-title":"Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"10","author":"Bell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.08.010_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"issue":"29(5)","key":"10.1016\/j.ymgme.2018.08.010_bb0055","first-page":"561","article-title":"Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia - effect on median Phe\/Tyr ratios","volume":"1","author":"Tansek","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.010_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ymgme.2015.02.003","article-title":"Phenylketonuria demographics, outcomes and safety registry. Long-term safety and efficacy of sapropterin: the PKUDOS registry experience","volume":"114","author":"Longo","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.08.010_bb0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1148\/78.3.394","article-title":"Roentgenologic findings in growing long bones in phenylketonuria. Preliminary study","volume":"78","author":"Feinberg","year":"1962","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2018.08.010_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archpedi.1964.02080060525013","article-title":"Roentgenologic bone changes in phenylketonuria. Relationship to dietary phenylalanine and serum alkaline phosphatase","volume":"107","author":"Murdoch","year":"1964","journal-title":"Am. J. Dis. Child."},{"issue":"7","key":"10.1016\/j.ymgme.2018.08.010_bb0075","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ultrasmedbio.2007.12.013","article-title":"Phalangeal quantitative ultrasound in children with phenylketonuria: a pilot study","volume":"34","author":"Porta","year":"2008","journal-title":"Ultrasound Med. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.010_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1651-2227.1998.tb01387.x","article-title":"Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography","volume":"87","author":"Schwahn","year":"1998","journal-title":"Acta Paediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.010_bb0085","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1651-2227.1999.tb01049.x","article-title":"Bone mineral density in patients with phenylketonuria","volume":"88","author":"Zeman","year":"1999","journal-title":"Acta Paediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.010_bb0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ajcn\/59.2.419","article-title":"Decreased bone mineral density in children with phenylketonuria","volume":"59","author":"Allen","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.010_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-015-9910-0","article-title":"Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency","volume":"39","author":"Coakley","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.08.010_bb0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1651-2227.2002.tb02852.x","article-title":"New approach to osteopenia in phenylketonuric patients","volume":"91","author":"P\u00e9rez-Due\u00f1as","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2018.08.010_bb0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","article-title":"Peak bone mass in patients with phenylketonuria","volume":"30","author":"Modan-Moses","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2018.08.010_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13023-015-0232-y","article-title":"Bone health in phenylketonuria: a systematic review and meta-analysis","volume":"15","author":"Demirdas","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.010_bb0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10545-014-9735-2","article-title":"A systematic review of bone mineral density and fractures in phenylketonuria","volume":"37","author":"Hansen","year":"2014","journal-title":"J. Inherit Metab Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.08.010_bb0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ymgme.2012.01.006","article-title":"Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients","volume":"105","author":"de Groot","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2018.08.010_bb0125","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1007\/s10545-010-9189-0","article-title":"Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density","volume":"33","author":"Lage","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.010_bb0130","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1651-2227.1999.tb01049.x","article-title":"Bone mineral density in patients with phenylketonuria","volume":"88","author":"Zeman","year":"1999","journal-title":"Acta Paediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.08.010_bb0135","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/PL00014234","article-title":"Decreased bone mineralization in children with phenylketonuria under treatment","volume":"155","author":"Hillman","year":"1996","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2018.08.010_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00774-010-0216-x","article-title":"Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria","volume":"29","author":"P1","year":"2011","journal-title":"J. Bone Miner. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2018.08.010_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00431-002-1091-9","article-title":"The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria","volume":"161","author":"P1","year":"2002","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2018.08.010_bb0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00774-011-0276-6","article-title":"Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening","volume":"29","author":"Nagasaka","year":"2011","journal-title":"J. Bone Miner. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2018.08.010_bb0155","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1007\/s10545-008-0907-9","article-title":"Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria","volume":"31","author":"Porta","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.08.010_bb0160","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/PL00014234","article-title":"Decreased bone mineralization in children with phenylketonuria under treatment","volume":"155","author":"Hillman","year":"1996","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2018.08.010_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1020191515173","article-title":"Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice","volume":"25","author":"Yannicelli","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.010_bb0170","first-page":"254","article-title":"Epigenomics in Neuropathology of PAH Deficient PKU in the Pahenu2 Model","volume":"117","author":"Dobrowolski","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2018.08.010_bb0175","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.010_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.ymgme.2018.08.010_bb0185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/labinvest.2016.51","article-title":"Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice","volume":"96","author":"Blair","year":"2016","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.ymgme.2018.08.010_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2003\/548678","article-title":"A feature set for cytometry on digitized microscopic images","volume":"25","author":"Rodenacker","year":"2003","journal-title":"Anal. Cell. Pathol."},{"issue":"3","key":"10.1016\/j.ymgme.2018.08.010_bb0195","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/mgme.2000.2974","article-title":"A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia","volume":"69","author":"Sarkissian","year":"2000","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2018.08.010_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045165","article-title":"Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet","volume":"7","author":"Solverson","year":"2012","journal-title":"PLoS One"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218304785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218304785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T08:49:10Z","timestamp":1661849350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218304785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1096719218304785"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bone mineralization defect in the Pahenu2 model of classical phenylketonuria involves compromised mesenchymal stem cell differentiation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}